These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4842261)

  • 1. Transient decline in serum progesterone levels during prostaglandin F2alpha infusion in the midluteal phase of the normal human menstrual cycle.
    Coudert SP; Winter JS; Faiman C
    Am J Obstet Gynecol; 1974 Jul; 119(6):755-61. PubMed ID: 4842261
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous infusion of prostaglandin F2alpha in the mid-luteal phase of the normal human menstrual cycle.
    Jewelewicz R; Cantor B; Dyrenfurth I; Warren MP; Vande Wiele RL
    Prostaglandins; 1972 Jun; 1(6):443-51. PubMed ID: 4660079
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of prostaglandin F2alpha on the luteal phase of the cycle in nonpregnant women.
    Arrata WS; Chatterton RT
    Am J Obstet Gynecol; 1974 Dec; 120(7):954-9. PubMed ID: 4429112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient luteolytic effect of prostaglandin F2alpha in the human.
    Wentz AC; Jones GS
    Obstet Gynecol; 1973 Aug; 42(2):172-81. PubMed ID: 4721404
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of vaginally administered prostaglandin F2alpha on corpus luteum function.
    Bolognese RJ; Corson SL
    Am J Obstet Gynecol; 1973 Sep; 117(2):240-5. PubMed ID: 4728875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of infusions with two analogues of prostaglandin F2alpha on corpus luteum function.
    Leader A; Bygdeman M; Eneroth P; Martin JN; Wiqvist N
    Adv Prostaglandin Thromboxane Res; 1976; 2():679-85. PubMed ID: 983868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of prostaglandin F2 alpha infusion on corpus luteum function.
    Jones GS; Wentz AG
    Am J Obstet Gynecol; 1972 Oct; 114(3):393-404. PubMed ID: 4637460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of the estrous cycle with prostaglandins.
    Downey BR
    Vet Med Small Anim Clin; 1974 Jul; 69(7):880 passim. PubMed ID: 4599998
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostaglandin F 2alpha: its effect on the corpus luteum of the menstrual cycle.
    LeMaire WJ; Shapiro AG
    Prostaglandins; 1972 Apr; 1(4):259-67. PubMed ID: 4660073
    [No Abstract]   [Full Text] [Related]  

  • 10. Immediate effect of prostaglandin F2alpha during the luteal phase of the menstrual cycle.
    Turksoy RN; Safaii HS
    Fertil Steril; 1975 Jul; 26(7):634-7. PubMed ID: 168099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sequential treatment with estradiol and PGF2alpha on the length of the primate menstrual cycle.
    Shaikh AA; Klaiber EL
    Prostaglandins; 1974 May; 6(3):253-62. PubMed ID: 4208678
    [No Abstract]   [Full Text] [Related]  

  • 12. Estrus, ovulation, progesterone and luteinizing hormone after prostaglandin F2a in mares.
    Noden PA; Oxender WD; Hafs HD
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):145-50. PubMed ID: 4855881
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase.
    Sherman BM; Korenman SG
    J Clin Endocrinol Metab; 1974 Jul; 39(1):145-9. PubMed ID: 4835128
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of ethinyl estradiol administration during the follicular phase of the menstrual cycle on LH, FSH, progesterone and estradiol levels in the subsequent luteal phase.
    Dhont M; Vandekerckhove D; Vermeulen A
    J Clin Endocrinol Metab; 1974 Sep; 39(3):465-70. PubMed ID: 4416191
    [No Abstract]   [Full Text] [Related]  

  • 15. Profile of serum luteinizing hormone, follicle stimulating hormone, estradiol-17beta and progesterone in normal human menstrual cycle.
    Dash RJ; Sharma BR; Sialy R; Vasisth K; Rastogi GK; Devi PK
    J Obstet Gynaecol India; 1977 Apr; 27(2):188-94. PubMed ID: 923993
    [No Abstract]   [Full Text] [Related]  

  • 16. Luteal deficiency among women with normal menstrual cycles, requesting reversal of tubal sterilization.
    Radwanska E; Berger GS; Hammond J
    Obstet Gynecol; 1979 Aug; 54(2):189-92. PubMed ID: 460752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the patterns of androstenedione, progesterone, and estradiol during the human menstrual cycle.
    Ribeiro WO; Mishell DR; Thorneycroft IH
    Am J Obstet Gynecol; 1974 Aug; 119(8):1026-32. PubMed ID: 4847439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma progesterone and prostaglandin F2 levels during the insertion of prostaglandin F2 vaginal tablet.
    Sato T; Ami K; Shinada T; Igarashi M
    Prostaglandins; 1973 Jul; 4(1):107-13. PubMed ID: 4728431
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor.
    Casper RF; Yen SS
    Science; 1979 Jul; 205(4404):408-10. PubMed ID: 377491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol-induced luteal regression in the rhesus monkey: evidence for an extraovarian site of action.
    Schoonmaker JN; Bergman KS; Steiner RA; Karsch FJ
    Endocrinology; 1982 May; 110(5):1708-15. PubMed ID: 6804210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.